News

Tufts CSDD

Analysis suggests age, condition, and treatment satisfaction have most significant effect on participation.

In August last year, the FDA came out with its Guidance for Industry Oversight of Clinical Investigations-a Risk-Based Approach to Monitoring. Sponsors and CROs alike are still examining the document and discussing how best to move forward.

Criticisms of the pharmaceutical industry's real motives for undertaking post-marketing studies have been made by a special report in the British Medical Journal.

The main result of the Supreme Court decision upholding the Affordable Care Act (ACA) is that it ends all the rampant speculation and uncertainty about the future shape of the US healthcare system.

Despite their growing role, little benchmark management data, until now, existed on global study monitors.

It's hard enough to conduct clinical trials for experimental medicines, but it can be even more difficult when patients already have access to the medicine outside the research setting.

Regulatory: Developing Biosimilars for a Global Market Subject Recruitment: Patient Interest in Clinical Trial Referral CRO/Sponsor: Functional Service Provider Model Also in this issue: Proposed Rule Changes in Europe Global Study Monitors Benchmarks Emergency Department Trials

Leader in Business Outcomes Provides Program to Help Pharmaceutical Developers and Contract Research Organizations Save Costs, Reduce Cycle Times

Quotient Clinical and Capsugel Announce Collaboration to Accelerate Early Development

Forte Research Systems has Created the Allegro® ePayments System for Research Sites and their Patients.

Strengthened Partnership Facilitates Advancements in Patient Engagement Solutions

Imperial Announces New Family of Companies Including Exclusive Life-Science Translation Provider

Multiple Parties Engaged: Aurora Health Care and UPMC Adopt Cloud-based Collaboration Solution to Accelerate Clinical Research & Development; Industry Consortium PACeR Plans to Leverage Oracle Health Sciences Network to Connect Its Participants

15 Sponsors Participate in Study Evaluating Clinical Trial Procedures Tied to Study Endpoints and Objectives

Organization Opens New Offices in Belgium and Ireland

OEM agreement brings full suite of AG Mednet quality assurance, submission compliance and image transfer technology to leading provider of medical imaging research services

Board will be one of the preeminent Oncology Boards in North America

Integrated Partnership With PharmaPros Dataflow Manager Enables New Functionality